The Health Economics Team at Canada’s Drug Agency is responsible for evaluating the economic impact of drugs and health technologies. They conduct robust analyses and modeling to provide evidence-based recommendations that inform decision-making within the health system. Collaborating with various stakeholders, the team aims to optimize healthcare resources and enhance the overall value of health interventions in Canada.